Aperio Group’s Teladoc Health TDOC Stock Holding History

Aperio Group’s Portfolio TDOC Stock Details TDOC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	$8.81M	Buy	44,062 +8,825	+25%	+$1.79M	0.03%	609
2020 Q3	$7.72M	Buy	35,237 +10,294	+41%	+$2.18M	0.03%	562
2020 Q2	$4.76M	Buy	24,943 +7,326	+42%	+$1.28M	0.02%	749
2020 Q1	$2.73M	Buy	17,617 +6,789	+63%	+$790K	0.01%	886
2019 Q4	$906K	Buy	10,828 +2,277	+27%	+$173K	﹤0.01%	1481
2019 Q3	$580K	Buy	8,551 +1,381	+19%	+$90.9K	﹤0.01%	1674
2019 Q2	$476K	Buy	7,170 +1,582	+28%	+$92.2K	﹤0.01%	1804
2019 Q1	$311K	Buy	5,588 +254	+5%	+$15.5K	﹤0.01%	1979
2018 Q4	$264K	Buy	5,334 +1,127	+27%	+$69K	﹤0.01%	2002
2018 Q3	$363K	Buy	4,207 +745	+22%	+$53.1K	﹤0.01%	1927
2018 Q2	$201K	Buy	+3,462	New	+$169K	﹤0.01%	2166

Other funds holding TDOC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

GCGM

General Catalyst Group Management Cambridge, Massachusetts $184M AUM 50.45% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Aperio Group's TDOC Position: Q4 2020 in Review

Aperio Group increased its Teladoc Health (TDOC) stake by 25% in Q4 2020, buying an estimated $1.79M and bringing the position to 44,062 shares worth $8.81M. The position accounts for 0.03% of the portfolio, ranked #609.

Aperio Group first reported a position in TDOC in Q2 2018 and has held it in 11 quarters since. 901 funds tracked by Wall St. Rank hold TDOC as of Q4 2020.

Aperio Group held 44,062 shares of Teladoc Health worth $8.81M as of Q4 2020.
Aperio Group bought 8,825 Teladoc Health shares in Q4 2020, an estimated $1.79M.
Teladoc Health made up 0.03% of Aperio Group's portfolio in Q4 2020, its #609 holding.
Aperio Group first reported a position in Teladoc Health in Q2 2018 and has held it in 11 quarters since.
901 funds tracked by Wall St. Rank held Teladoc Health as of Q4 2020.

Based on Aperio Group's 13F filing for Q4 2020, filed 5 Feb 2021.